✦ LIBER ✦

499 The impact of sustained virological response (SVR) on health-related quality of life (HRQL) in patients with chronic hepatitis C (CHC) and persistently normal ALT levels (PNALT) treated with peginterferon alfa-2A (PEGASYS®) and ribavirin (COPEGUS®)

✍ Scribed by C. O'Brien; N. Wintfeld; K.K. Patel; S. Zeuzem; M.L. Shiffman; M. Diago; A. Tran; P. Pockros; J. Green

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

503 Early prediction of sustained virolo

✍ P.J. Pockros; M. Diago; E. Gane; K.R. Reddy; D. Prati; M.L. Shiffman; P. Farci; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PIN3 COST-EFFECTIVENESS ANALYSIS OF COMB

✍ C Rubio Terres; C Álvarez Sanz; KK Patel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

106 International, multicenter, randomiz

✍ Stefan Zeuzem; Moisés Diago; Edward Gane; Rajender Reddy; Paul Pockros; Patrizia 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

505 The influence of cumulative exposure

✍ K.R. Reddy; M.W. Fried; M.L. Shiffman; S.J. Hadziyannis; H. Sette; T.R. Morgan; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Sustained virological response rates and

✍ E. J. BINI; S. MEHANDRU 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB